Literature DB >> 24228047

Real-world application of MedsCheck opportunities: The Costco pharmacists intervention trial for reduction of cardiovascular risk.

Joseph Hanna1.   

Abstract

Year:  2013        PMID： 24228047      PMCID： PMC3819959          DOI： 10.1177/1715163513506831

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN： 1715-1635


× No keyword cloud information.
  8 in total

1.  Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease.

Authors:  Ruth McPherson; Jiri Frohlich; George Fodor; Jacques Genest
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

2.  Pharmacists' ability to influence outcomes of hypertension therapy.

Authors:  S R Erickson; R Slaughter; H Halapy
Journal:  Pharmacotherapy       Date:  1997 Jan-Feb       Impact factor: 4.705

3.  The physician and pharmacist team. An effective approach to cholesterol reduction.

Authors:  P E Bogden; L M Koontz; P Williamson; R D Abbott
Journal:  J Gen Intern Med       Date:  1997-03       Impact factor: 5.128

Review 4.  Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials.

Authors:  Valérie Santschi; Arnaud Chiolero; Bernard Burnand; April L Colosimo; Gilles Paradis
Journal:  Arch Intern Med       Date:  2011-09-12

5.  Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers.

Authors:  S L Ellis; B L Carter; D C Malone; S J Billups; G J Okano; R J Valuck; D J Barnette; C D Sintek; D Covey; B Mason; S Jue; J Carmichael; K Guthrie; R Dombrowski; D R Geraets; M Amato
Journal:  Pharmacotherapy       Date:  2000-12       Impact factor: 4.705

6.  Effect of a clinical pharmacist-managed lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goals.

Authors:  M Bozovich; C M Rubino; J Edmunds
Journal:  Pharmacotherapy       Date:  2000-11       Impact factor: 4.705

7.  Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension.

Authors:  P E Bogden; R D Abbott; P Williamson; J K Onopa; L M Koontz
Journal:  J Gen Intern Med       Date:  1998-11       Impact factor: 5.128

Review 8.  Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Valérie Santschi; Arnaud Chiolero; Gilles Paradis; April L Colosimo; Bernard Burnand
Journal:  Diabetes Care       Date:  2012-12       Impact factor: 19.112
  8 in total
  2 in total

1.  Impact of a community pharmacist-led medication review on medicines use in patients on polypharmacy--a prospective randomised controlled trial.

Authors:  Markus Messerli; Eva Blozik; Noortje Vriends; Kurt E Hersberger
Journal:  BMC Health Serv Res       Date:  2016-04-23       Impact factor: 2.655

2.  Innovating medication reviews through a technology-enabled process.

Authors:  Kaeshaelya Thiruchelvam; Julie Byles; Syed Shahzad Hasan; Therese Kairuz
Journal:  Res Social Adm Pharm       Date:  2021-07-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.